The bispecifc space has come a long way since this conference frst ran 10 years ago.Seemingly insurmountable engineering roadblocks have tumbled along the way, opening up the path to the unprecedented clinical progress and accompanying investment in the feld that we now see.
Returning for the tenth year, World Bispecifc will encapsulate this progress through a completely reimagined agenda, packed with more focused content than any other bispecifc conference. This is your opportunity to streamline high-throughput discovery approaches,maintain safety and efcacy throughout preclinical and clinical development and overcome the unique analytical challenges posed by complex multispecifc therapeutics.
For these insights to be useful, they need to be delivered people actively involved in making the decisions that matter. That’s why for the 2019 meeting, I'm particularly looking forward to hearing from a greater range of companies than ever before, representing the pharma,biotech and academic organizations at the forefront of driving progress.
If you are or want to become a player in the bispecifc arena, this is the conference you should attend to both learn and make valuable connections that will help drive your bispecifc development forward and turn the promise of these therapeutics into a reality for patients.